发明名称 Diabetic control by combined insulin forms
摘要 Peripherally administered insulin fails to provide liver hormone function. Hepatocyte directed vesicles with encapsulated insulin will restore liver function, but there is no non-targeted insulin to bypass the liver for peripheral use, as in natural, healthy body function. Whenever a prescribed dosage of insulin is divided between free and encapsulated hepatocyte targeted forms, a very small fraction of the dose in encapsulated form is sufficient to elicit full liver function, and non-targeted insulin supplies the needs of the body muscle and tissue.
申请公布号 US4863896(A) 申请公布日期 1989.09.05
申请号 US19880143180 申请日期 1988.01.13
申请人 TECHNOLOGY UNLIMITED, INC. 发明人 GEHO, W. BLAIR;LAU, JOHN R.
分类号 A61K8/14;A61K9/127;A61K38/28;A61K47/48;A61Q11/00 主分类号 A61K8/14
代理机构 代理人
主权项
地址